Please don’t buy this stock unless you can hold it for a year. If not you will be wasting your time and money
jayg55
Posts
-
-
Rate cuts after the election in November. Until then no rate cuts.
-
No chance of rate hikes. ARR is extremely oversold
-
Back to $1.60 by tomorrow
-
They need to raise 20mil. Only way to do that will be a reverse split and sell more shares if they can. Dilution is the least of the problem most important is the continuation of the company as a going concern.
-
Google might be interested in acquiring ICAD. This could become the crown jewel of Google Health.
-
Estimated 7c. Vs actual 10c
-
Looks like a pump and dump
-
ASRT is extremely oversold
-
Looks like this is a dead stock
-
Looks like nobody wants ICAD.
-
Securid is small startup company headquartered in Tokyo, Japan with around 10 employees
-
This is the only broken down stock that’s not moving higher
-
Any one with money buy up 800000 shares and get the stock certificates for 400000 shares will create gigantic short squeeze and will make 10 times their investment
-
CYTO has only a 400000 share float. It can move up to $100
-
Let’s take it up to $100 only 400k float
-
Do not think your shares are of less value because of the reverse split. Company has enough cash and has no need to issue more shares.
-
It’s the same company nothing changed except the number of shares. Instead of 8million shares we will have 400,000 shares. This is to satisfy NASDQ minimum $1 share price requirement.
-
Will somebody move CYTO to a $1
-
SOUN unless you can hold the stock for at least 6 months, do yourself a favor don’t buy the stock, it’s not going to do much in the short run
ICAD
ARR
ARR
ICAD
EYEN
ICAD
OPFI
SOUN
ASRT
ICAD
ICAD
IDAI
ICAD
CYTO
CYTO
CYTO
CYTO
CYTO
CYTO
SOUN